Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Receivables - Net: 2010-2024

Historic Receivables - Net for Altimmune (ALT) over the last 15 years, with Dec 2024 value amounting to $544,000.

  • Altimmune's Receivables - Net rose 97.43% to $845,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $845,000, marking a year-over-year increase of 97.43%. This contributed to the annual value of $544,000 for FY2024, which is 51.04% down from last year.
  • Altimmune's Receivables - Net amounted to $544,000 in FY2024, which was down 51.04% from $1.1 million recorded in FY2023.
  • In the past 5 years, Altimmune's Receivables - Net registered a high of $4.6 million during FY2020, and its lowest value of $173,000 during FY2022.
  • Its 3-year average for Receivables - Net is $609,333, with a median of $544,000 in 2024.
  • As far as peak fluctuations go, Altimmune's Receivables - Net crashed by 90.69% in 2021, and later skyrocketed by 542.20% in 2023.
  • Yearly analysis of 5 years shows Altimmune's Receivables - Net stood at $4.6 million in 2020, then tumbled by 90.69% to $429,000 in 2021, then plummeted by 59.67% to $173,000 in 2022, then soared by 542.20% to $1.1 million in 2023, then tumbled by 51.04% to $544,000 in 2024.